LATEST: Semler Scientific Acquires 828 BTC, Eyes $150M Additional Purchase

Semler Scientific, a Nasdaq-listed medical manufacturer, has aggressively increased its Bitcoin portfolio, purchasing an additional $17 million of the cryptocurrency. This latest acquisition boosts the firm’s total Bitcoin holdings to 828, valued at over $58.5 million. The move aligns with Semler’s strategy to strengthen its financial reserves with Bitcoin, citing its potential as a stable store of value and a hedge against inflation.

The company announced plans to potentially raise up to $150 million through debt securities, earmarking a significant portion of this for further Bitcoin investments. Semler’s commitment to Bitcoin underscores its belief in the digital asset’s superiority over traditional assets like gold, anticipating substantial returns as Bitcoin gains more recognition as “digital gold.”

Despite a slight decline in Semler’s stock following the recent purchase, the firm remains optimistic. CEO Doug Murphy-Chutorian emphasized that integrating Bitcoin into Semler’s treasury is now a key focus, parallel to its core healthcare operations. This strategic pivot highlights Bitcoin’s growing acceptance and stability as an investment, even amid global economic uncertainties.

Source

Hulk Hogan-Themed Crypto Loses $15M in Market Cap In Minutes: Here’s Why

A Solana SOL/USD-based memecoin promoted by Hulk Hogan reportedly suffered a $15 million loss in market cap after the wrestling legend allegedly deleted social posts shilling the cryptocurrency.

What Happened: HULK‘s value plunged from $17 million to a mere $2 million within minutes of Hogan’s supposed deletions, according to a post by a Solana-associated X account Thursday.

Widely-followed journalist Matt Binder posted screenshots, allegedly showing promotional posts by Hogan earlier in the day. In one of the posts, Hogan wrote, “Website hulkhogan.com is #updated with the $HULK info! I’m all jacked up for tonight!”

The posts have been removed as of this writing, and Hogan later…

Read more on Benzinga